Literature DB >> 9683021

Opioid activity of alkaloids extracted from Picralima nitida (fam. Apocynaceae).

J R Menzies1, S J Paterson, M Duwiejua, A D Corbett.   

Abstract

Extracts of the seeds of Picralima nitida (fam. Apocynaceae) have been reported to have opioid analgesic activity. In this investigation, isolated tissue bioassays and radioligand binding assays have been used to determine the opioid activity of five alkaloids--akuammidine, akuammine, akuammicine, akuammigine and pseudoakuammigine--extracted from the seeds of P. nitida. Akuammidine showed a preference for mu-opioid binding sites with Ki values of 0.6, 2.4 and 8.6 microM at mu-, delta- and kappa-opioid binding sites, respectively. The agonist actions of akuammidine in the mouse-isolated vas deferens were antagonised by naloxone and the mu-opioid receptor selective antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) confirming an action at mu-opioid receptors. In contrast, akuammine also showed highest affinity for mu-opioid binding sites (Ki 0.5 microM) but was an antagonist at mu-opioid receptors with a pK(B) of 5.7 against the selective mu-opioid receptor agonist [D-Ala2,MePhe4,Gly-ol5]enkephalin (DAMGO). Akuammicine has the highest affinity for kappa-opioid binding sites (Ki 0.2 microM) and was a full agonist at kappa-opioid receptors in the guinea pig ileum preparation but a partial kappa-opioid receptor agonist in the vasa deferentia of the mouse and the rabbit. Akuammigine and pseudoakuammigine showed little or no efficacy in the opioid bioassays. None of the alkaloids had significant activity for opioid receptor-like binding sites (ORL1-binding sites) with Ki values >> 10 microM. These data show that some alkaloids extracted from the medicinal plant P. nitida possess varying degrees of agonist and antagonist activity at opioid receptors but possess neither high affinity nor selectivity for mu-, delta- or kappa-opioid receptors or the ORL1-receptor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9683021     DOI: 10.1016/s0014-2999(98)00232-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

Review 1.  Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity.

Authors:  Michael S Toce; Peter R Chai; Michele M Burns; Edward W Boyer
Journal:  J Med Toxicol       Date:  2018-10-30

2.  Isolation and Pharmacological Characterization of Six Opioidergic Picralima nitida Alkaloids.

Authors:  Simone M Creed; Anna M Gutridge; Malaika D Argade; Madeline R Hennessy; J Brent Friesen; Guido F Pauli; Richard M van Rijn; Andrew P Riley
Journal:  J Nat Prod       Date:  2020-12-16       Impact factor: 4.050

3.  Integrating carbon-halogen bond formation into medicinal plant metabolism.

Authors:  Weerawat Runguphan; Xudong Qu; Sarah E O'Connor
Journal:  Nature       Date:  2010-11-03       Impact factor: 49.962

4.  Antitussive, expectorant and analgesic effects of the ethanol seed extract of Picralima nitida (Stapf) Th. & H. Durand.

Authors:  Gabriel Dapaah; George Asumeng Koffuor; Priscilla Kolibea Mante; Inemesit Okon Ben
Journal:  Res Pharm Sci       Date:  2016 Mar-Apr

5.  Assessment of an ethanolic seed extract of Picralima nitida ([Stapf] Th. and H. Durand) on reproductive hormones and its safety for use.

Authors:  Lydia Francisca Otoo; George Asumeng Koffuor; Charles Ansah; Kwesi Boadu Mensah; Charles Benneh; Inemesit Okon Ben
Journal:  J Intercult Ethnopharmacol       Date:  2015-11-02

6.  A three enzyme system to generate the Strychnos alkaloid scaffold from a central biosynthetic intermediate.

Authors:  Evangelos C Tatsis; Inês Carqueijeiro; Thomas Dugé de Bernonville; Jakob Franke; Thu-Thuy T Dang; Audrey Oudin; Arnaud Lanoue; Florent Lafontaine; Anna K Stavrinides; Marc Clastre; Vincent Courdavault; Sarah E O'Connor
Journal:  Nat Commun       Date:  2017-08-22       Impact factor: 17.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.